Ajooni Biotech Submits SEBI Regulation 74(5) Certificate

Date: July 14, 2026

Regulatory Compliance Submission

Ajooni Biotech Limited submitted a mandatory compliance certificate to the National Stock Exchange of India Ltd as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.

The certificate was issued by the company's Registrar and Transfer Agent (RTA), Cameo Corporate Services Limited, dated July 3, 2026 (Ref: CAM/AJO/74(5)/Q1/2026).

Certificate Contents

The RTA certificate confirms that:

• All securities received from depository participants for dematerialization during Q1 FY2027 (quarter ended June 30, 2026) were properly confirmed (accepted/rejected) to the depositories
• The securities comprised in the said certificates have been listed on the stock exchanges where the company's previously issued securities are listed
• All security certificates received for dematerialization were mutilated and cancelled after due verification by the depository participant
• The names of the depositories have been substituted in the register of members as the registered owner within the stipulated time limits under the regulations